Vasogen Files Shelf Prospectus

On Octover 17, 2003, Canadian bio-technology company Vasogen Inc., filed a shelf prospectus in Canada and a registration statement with the US Securities and Exchange Commission to establish a US$100 million shelf for offerings of commons shares in the US and Canada under the multijurisdictional disclosure system.

Vasogen was represented in Canada by Lang Michener LLP, with a team that included Geofrey Myers, Hellen Siwanowicz and Adam Taylor; and in the US by Paul, Weiss, Rifkind, Wharton & Garrison LLP in New York, with a team that included Edwin Maynard, Gustav Bahn and David Tayar.